Save my progress and resume later | Resume a previously saved form

Resume Later

In order to be able to resume this form later, please enter your email and choose a password.

Your Email:

A Password:

Confirm Password:

Step 1

Prostate Cancer Foundation of Australia Review of the Clinical Practice Guidelines for PSA Testing

Public Comment Period

This consultation is seeking written submissions from Australians who wish to comment on the 2016 Clinical Practice Guidelines for Prostate Specific Antigen (PSA) Testing and Early Management of Test-detected Prostate Cancer (the 2016 Guidelines).

Submissions will be used to inform the development of revised guidelines to be released in 2025.

This public consultation aligns with the National Health and Medical Research Council endorsed process for guideline review. The process is overseen by a Project Steering Committee comprising consumer, community and industry representatives, a 51 member multi-disciplinary Expert Advisory Panel (EAP) and 12 EAP Working Groups.

The deadline for comments is 5pm on Friday 31 May, 2024.

Click here for more information on the public comment period.

You can make a submission by completing this form online, or sending your comments via email or post (click here to download a PDF copy of the survey questions). Please send correspondence to the addresses provided below.

Submit via email:

research@pcfa.org.au

Submit via post:

To the Steering Committee

Review of Guidelines for PSA Testing

PO Box 499

St Leonards NSW 1590

Privacy Information

Any personal information collected via this website will be stored and used in accordance with PCFA’s obligations under the Privacy Act 1988, and in accordance with the PCFA Privacy Policy. All information collected will be de-identified for reporting purposes.

Privacy Collection Notice

I have read and understood the security warning/disclaimer in the Privacy Information notice and accept the risks and conditions outlined.

^* indicates a required field

Step 2

Personal / organisational information

First Name

Last Name

Email

Gender: How do you identify?

Postcode

Does this submission reflect the views of an individual, organisation or group?

Do you identify with any of the following

Aboriginal and Torres Strait Islander peoplesPeople living in a rural or remote areaLGBTQIA+People from culturally and linguistically diverse communitiesNone of the abovePlease select any that apply

State or Territory?

Individual background

Please provide more information

What is the name of your organisation?

What is the name of your group?

^* indicates a required field

Step 3

Questions about the 2016 Guidelines

Below are some general questions on the 2016 Guidelines. You don’t need to answer all sections or questions, only ones that are of interest to you.

Have the 2016 Guidelines been effective? Please explain your view.

How can the Guidelines be strengthened to improve outcomes for people impacted by prostate cancer?

Do you consider the Guidelines easy to understand? Please explain your view.

In your experience, have the Guidelines aided decision-making at the General Practice level in Australia? Please explain your view.

How can we improve the effectiveness of the Guidelines for the Australian community broadly, and for marginalised communities and at-risk groups?

Please tell us more about your experience of prostate cancer, in relationship to the Guidelines and your response to the questions above.

Are there any other comments you would like the Guideline Steering Committee to consider?

Submit

If you would like us to email you a copy of your submission please tick this box

Please email me a full copy of my submission. (Please allow 2 business days for us to send you your submission.)

Save my progress and resume later | Resume a previously saved form